Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • PEX010Registry product

    Linked study entry; product equivalence not established

    Formulation reported by source: CAPSULES

    View study and source

Success Metrics

Active Trials
0(0%)

Phase Distribution

Phase 2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

not_yet_recruiting1100%

Recent Activity

0 active trials
Showing 1 of 1
not_yet_recruitingphase_2

The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT)

SYF028d75320768425f894d95e26f3a6b81

Clinical Trials (1)

Showing 1 of 1 trials
SYF028d75320768425f894d95e26f3a6b81Phase 2

The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT)

Not Yet Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Type not reported
Total Trials
1